DAY ONE BIOPHARMACEUTICALS, INC.
Clinical trial NCT07206849 updates: 1. start date: 2026-05-01 → 2026-11-01 2. completion date: 2037-05-01 → 2037-11-01 3. primary completion date: 2030-05-01 → 2030-11-01
Clinical trial NCT07206849 updates: 1. start date: 2026-05-01 → 2026-11-01 2. completion date: 2037-05-01 → 2037-11-01 3. primary completion date: 2030-05-01 → 2030-11-01
📉 **NEGATIVE** • Medium confidence analysis (66%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (22%) **Content type:** Clinical